Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 141,150 | 163,152 | 182,160 | 322,536 | 292,735 |
| Marketable Securities | 208,399 | 180,870 | 139,215 | N/A | N/A |
| Receivables | 190,904 | 199,444 | 196,231 | 152,380 | 160,467 |
| Inventories | 192,405 | 184,500 | 173,370 | 160,342 | 156,007 |
| Income taxes - deferred | 36,767 | 37,509 | 36,291 | 37,689 | 33,258 |
| Other current assets | 63,771 | 67,559 | 81,642 | 86,451 | 60,154 |
| TOTAL | $833,396 | $833,034 | $808,909 | $759,398 | $702,621 |
| Non-Current Assets | |||||
| PPE Net | 320,337 | 326,041 | 309,827 | 303,587 | 291,701 |
| Intangibles | 239,042 | 237,222 | 236,843 | 249,572 | 235,747 |
| Other Non-Current Assets | 84,435 | 81,073 | 75,435 | 71,654 | 60,563 |
| TOTAL | $643,814 | $644,336 | $622,105 | $624,813 | $588,011 |
| Total Assets | $1,477,210 | $1,477,370 | $1,431,014 | $1,384,211 | $1,290,632 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 53,614 | 58,212 | 44,183 | 44,743 | 58,255 |
| Accrued Expenses | 203,738 | 190,441 | 177,942 | 195,351 | 167,449 |
| TOTAL | $824,766 | $775,428 | $803,445 | $820,906 | $630,264 |
| Non-Current Liabilities | |||||
| Long Term Debt | 599,556 | 622,796 | 522,350 | 350,000 | 371,549 |
| Deferred Revenues | N/A | 28,775 | 31,820 | 31,812 | 29,560 |
| Other Non-Current Liabilities | 29,654 | 31,308 | 31,043 | 32,373 | 31,567 |
| TOTAL | $691,247 | $693,391 | $593,490 | $445,716 | $430,897 |
| Total Liabilities | $1,516,013 | $1,468,819 | $1,396,935 | $1,266,622 | $1,061,161 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,964 | 92,005 | 93,591 | 94,251 | 95,365 |
| Common Shares | 10,213 | 10,235 | 10,226 | 10,195 | 10,170 |
| Retained earnings | 274,005 | 231,070 | 1,721,893 | 1,675,299 | 1,649,337 |
| Other shareholders' equity | -31,829 | -16,432 | -18,622 | -3,198 | 7,751 |
| TOTAL | $-38,803 | $8,551 | $34,079 | $117,589 | $229,471 |
| Total Liabilities And Equity | $1,477,210 | $1,477,370 | $1,431,014 | $1,384,211 | $1,290,632 |